Effect of denosumab versus zoledronic acid in patients with castrate-resistant prostate cancer and bone metastases: Subgroup analyses by prior SRE and baseline pain.
N. D. Shore
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen
M. R. Smith
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen
M. Jievaltas
No relevant relationships to disclose
K. Fizazi
Consultant or Advisory Role - Amgen
Honoraria - Amgen
R. DamiĆ£o
No relevant relationships to disclose
J. Chin
Consultant or Advisory Role - Amgen
Research Funding - Amgen
K. Miller
Consultant or Advisory Role - Amgen
Honoraria - Amgen
J. P. Maroto
No relevant relationships to disclose
Y. Qian
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
A. Feng
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
K. Chung
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
C. D. Goessl
Employment or Leadership Position - Amgen
Stock Ownership - Amgen